IGC Pharma (IGC) Return on Invested Capital (2016 - 2019)
IGC Pharma (IGC) has disclosed Return on Invested Capital for 9 consecutive years, with 0.08% as the latest value for Q4 2019.
- Quarterly Return on Invested Capital changed N/A to 0.08% in Q4 2019 from the year-ago period, while the trailing twelve-month figure was 0.08% through Dec 2019, changed N/A year-over-year, with the annual reading at 0.04% for FY2019, N/A changed from the prior year.
- Return on Invested Capital for Q4 2019 was 0.08% at IGC Pharma, down from 0.07% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.02% in Q2 2018, with the low at 0.14% in Q2 2017.
- Average Return on Invested Capital over 5 years is 0.08%, with a median of 0.09% recorded in 2015.
- The sharpest move saw Return on Invested Capital fell -11bps in 2016, then increased 17bps in 2018.
- Over 5 years, Return on Invested Capital stood at 0.03% in 2015, then plummeted by -354bps to 0.12% in 2016, then increased by 10bps to 0.11% in 2017, then surged by 122bps to 0.02% in 2018, then plummeted by -432bps to 0.08% in 2019.
- According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.08%, 0.07%, and 0.05% for Q4 2019, Q3 2019, and Q2 2019 respectively.